4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-22-062177
Director sold 10,291 shares at $35.61 ($366,500)
- Director acquired 10,291 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZASLOFF MICHAEL A Director | 2022-05-16 | Option exercise | +10,291 | $17.11 | $176,079 | 57,497 | D |
| ZASLOFF MICHAEL A Director | 2022-05-16 | Sale | −10,291 | $35.61 | $366,500 | 47,206 | D |
| Derivatives | |||||||
| ZASLOFF MICHAEL A Director | 2022-05-16 | Option exercise · Stock Option (right to buy) | −10,291 | 0 | D | ||
| Open-market sales · 10,291 sh · avg $35.61 · $366,500 | |||||||
Loading xslF345X03/tm2215857-1_4seq1.xml…